13.31
price down icon0.15%   -0.02
pre-market  시장 영업 전:  13.21   -0.10   -0.75%
loading
전일 마감가:
$13.33
열려 있는:
$13.34
하루 거래량:
4.84M
Relative Volume:
0.55
시가총액:
$3.50B
수익:
$6.16B
순이익/손실:
$246.00M
주가수익비율:
14.18
EPS:
0.9387
순현금흐름:
$708.00M
1주 성능:
-0.30%
1개월 성능:
+50.74%
6개월 성능:
+72.63%
1년 성능:
+52.81%
1일 변동 폭
Value
$13.28
$13.34
1주일 범위
Value
$13.28
$13.44
52주 변동 폭
Value
$5.69
$13.44

오가논 & Co Stock (OGN) Company Profile

Name
명칭
Organon Co
Name
전화
551-430-6000
Name
주소
30 HUDSON STREET, JERSEY CITY
Name
직원
10,000
Name
트위터
Name
다음 수익 날짜
2026-04-30
Name
최신 SEC 제출 서류
Name
OGN's Discussions on Twitter

Compare OGN vs LLY, JNJ, ABBV, AZN, NVS

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
OGN icon
OGN
Organon Co
13.31 3.50B 6.16B 246.00M 708.00M 0.9387
LLY icon
LLY
Lilly Eli Co
989.87 862.31B 72.25B 25.28B 10.37B 27.78
JNJ icon
JNJ
Johnson Johnson
224.26 533.03B 96.36B 21.04B 17.80B 8.6488
ABBV icon
ABBV
Abbvie Inc
207.86 358.27B 62.82B 3.60B 19.98B 2.0274
AZN icon
AZN
Astrazeneca Plc
184.54 282.04B 60.48B 10.40B 8.05B 3.3297
NVS icon
NVS
Novartis Ag Adr
148.16 277.11B 54.66B 13.58B 16.05B 7.0171

오가논 & Co Stock (OGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-12-09 개시 Barclays Underweight
2025-10-27 다운그레이드 Piper Sandler Overweight → Underweight
2025-05-02 다운그레이드 Evercore ISI Outperform → In-line
2024-09-06 다운그레이드 JP Morgan Neutral → Underweight
2023-11-03 다운그레이드 Goldman Buy → Neutral
2023-09-21 개시 Barclays Overweight
2023-03-16 개시 Raymond James Outperform
2022-10-14 다운그레이드 BofA Securities Neutral → Underperform
2022-09-06 업그레이드 Piper Sandler Neutral → Overweight
2022-08-05 다운그레이드 BofA Securities Buy → Neutral
2022-04-27 개시 Goldman Buy
2022-04-06 재개 Morgan Stanley Equal-Weight
2021-10-07 개시 Piper Sandler Neutral
2021-09-01 개시 BofA Securities Buy
2021-07-22 개시 Citigroup Buy
2021-06-15 개시 JP Morgan Neutral
2021-06-11 개시 Morgan Stanley Equal-Weight
2021-06-10 개시 Evercore ISI Outperform
모두보기

오가논 & Co 주식(OGN)의 최신 뉴스

pulisher
May 12, 2026

Organon & Co is the best performing healthcare stock in April - MSN

May 12, 2026
pulisher
May 12, 2026

What Sparked Organon's Recent Stock Surge - Kavout

May 12, 2026
pulisher
May 12, 2026

Notable healthcare headlines for the week: J&J, Abbott and Organon in focus - MSN

May 12, 2026
pulisher
May 12, 2026

Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more - MSN

May 12, 2026
pulisher
May 11, 2026

Sun Pharma shares jump after Organon acquisition deal; top gainer on Nifty 50 - MSN

May 11, 2026
pulisher
May 11, 2026

Mega Sun Pharma-Organon Deal | Organon A Strategic Fit For Sun Pharma, Says Macquarie Capital (Wch7sn8ZBU) - fathomjournal.org

May 11, 2026
pulisher
May 11, 2026

Organon & Co. Opens with 23.72% Gain, Surpassing S&P 500's 0.8% Rise - Markets Mojo

May 11, 2026
pulisher
May 10, 2026

Sun Pharma shares jump 9% as $11.75‑billion Organon buy seals entry into biosimilars, deal expected to close in 2027 - MSN

May 10, 2026
pulisher
May 10, 2026

Win-win deal! Sun Pharma jumps 8% in two days with Organon zooming 42% in five daysAll about acquisition - MSN

May 10, 2026
pulisher
May 10, 2026

Organon & Co (OGN) News Flow - Moomoo

May 10, 2026
pulisher
May 10, 2026

What does Sun Pharma gain from its $12-billion Organon bid? - MSN

May 10, 2026
pulisher
May 10, 2026

Sun Pharma’s $11.75 Billion Organon Deal: Dilip Shanghvi’s Bold Move Taking India to the World - Open Magazine

May 10, 2026
pulisher
May 10, 2026

Sun Pharma to acquire Organon in $11.75 billion all-cash deal - MSN

May 10, 2026
pulisher
May 10, 2026

India's largest drugmaker Sun Pharma to buy US firm Organon in $11.75 billion deal; shares jump 7% - MSN

May 10, 2026
pulisher
May 10, 2026

Organon stock surges 31% on sweetened $13 billion takeover offer from Sun Pharma - MSN

May 10, 2026
pulisher
May 09, 2026

MSN Money - MSN

May 09, 2026
pulisher
May 09, 2026

India’s Sun Pharma takes biosimilar leap with $11.75 billion all-cash Organon acquisition - MSN

May 09, 2026
pulisher
May 09, 2026

Sun Pharma's $11.75-billion Organon deal: What it means for Indian pharma M&As - MSN

May 09, 2026
pulisher
May 09, 2026

'Buy' Sun Pharma shares: Up to 34% upside? What experts say on India's biggest ever pharma deal Organon - MSN

May 09, 2026
pulisher
May 09, 2026

BT explainer: Why Sun Pharma's $11.75-bn Organon deal is priced below past pharma acquisitions - MSN

May 09, 2026
pulisher
May 09, 2026

Sun Pharma to acquire Organon in $11.75 billion deal; eyes global top 25 spot - MSN

May 09, 2026
pulisher
May 09, 2026

Organon jumps 15% as Sun Pharma agrees $11.8bn buyout - MSN

May 09, 2026
pulisher
May 08, 2026

OGN (OGN) Form 144: multiple RSU vestings and dividend-equivalent share listings - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Sun Pharma to buy Organon in $11.75B deal, expanding global reach - MSN

May 08, 2026
pulisher
May 08, 2026

Organon & Co To Go Ex-Dividend On May 11th, 2026 With 0.02 USD Dividend Per Share - Moomoo

May 08, 2026
pulisher
May 08, 2026

Organon & Co. (OGN) 10K Form and Latest SEC Filings 2026 - MarketBeat

May 08, 2026
pulisher
May 08, 2026

India’s Sun Pharma plots $12 billion Organon buyout for global reach - MSN

May 08, 2026
pulisher
May 07, 2026

Sun Pharmaceutical share: Brokerages turn bullish post Organon deal, peg up to 16% upside; check latest target prices - MSN

May 07, 2026
pulisher
May 07, 2026

Organon SVP, corporate controller Holzbaur sells $353,080 stock By Investing.com - Investing.com Australia

May 07, 2026
pulisher
May 07, 2026

Organon SVP, corporate controller Holzbaur sells $353,080 stock - Investing.com

May 07, 2026
pulisher
May 07, 2026

Organon (OGN) controller sells 26,448 shares, ends direct stake - Stock Titan

May 07, 2026
pulisher
May 07, 2026

OGN SEC FilingsORGANON & CO 10-K, 10-Q, 8-K Forms - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Organon Insider Bought Shares Worth $353,080, According to a Recent SEC Filing - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

OGN | Organon & Co. FinancialsIncome Statement - Quiver Quantitative

May 07, 2026
pulisher
May 07, 2026

Organon SVP Lynette Holzbaur acquires $353,080 in company stock By Investing.com - Investing.com South Africa

May 07, 2026
pulisher
May 07, 2026

Organon SVP Lynette Holzbaur acquires $353,080 in company stock - Investing.com

May 07, 2026
pulisher
May 07, 2026

Organon (OGN) controller boosts stake with 26,448-share purchase - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Organon & Co stock hits 52-week high at 13.4 USD - Investing.com Australia

May 07, 2026
pulisher
May 07, 2026

Organon Buyout By Sun Pharma Shifts Focus To Cash Value And Timing - Yahoo Finance

May 07, 2026
pulisher
May 07, 2026

Research Alert: CFRA Retains Hold Rating On Shares Of Organon & Co. Following Q1 Results - Moomoo

May 07, 2026
pulisher
May 07, 2026

Organon & Co stock hits 52-week high at 13.4 USD By Investing.com - Investing.com South Africa

May 07, 2026
pulisher
May 06, 2026

How big is Organon’s biosimilar push for Sun Pharma? - MSN

May 06, 2026
pulisher
May 06, 2026

Sun Pharma Signs Definitive Agreement to Acquire Organon & Company in $11.75 Billion Deal - scanx.trade

May 06, 2026
pulisher
May 06, 2026

Halper Sadeh LLC is Investigating Whether HLX, OGN, XOMA, RMAX are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.

May 06, 2026
pulisher
May 06, 2026

Son rise at Sun: Decoding the architecture of Dilip Shanghvi’s global empire - Mint

May 06, 2026
pulisher
May 06, 2026

Sun Pharma explores funding mix for $12 billion Organon deal - ET Pharma

May 06, 2026
pulisher
May 06, 2026

Organon shares rally 16% in premarket as Sun Pharma announces buyout - MSN

May 06, 2026
pulisher
May 06, 2026

Sun Pharma to acquire Organon for $11.75bn - MSN

May 06, 2026

오가논 & Co (OGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
PFE PFE
$25.87
price up icon 0.23%
$134.94
price up icon 1.06%
$336.29
price up icon 2.03%
NVO NVO
$47.00
price up icon 1.29%
MRK MRK
$112.37
price up icon 0.98%
NVS NVS
$148.16
price up icon 2.02%
자본화:     |  볼륨(24시간):